The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

Policy Notices

• Reminder to AHRQ Grantees that FY2015 Funds will Expire on September 30, 2020
• REMINDER - Expiring Funds Alert to AHRQ Grant Recipients who Received Multi-Year Funded Awards
  Agency for Healthcare Research and Quality

• NIH and AHRQ Announce Upcoming Changes to Policies, Instructions and Forms for Research Training Grant, Fellowship, and Career Development Award Applications
  Agency for Healthcare Research and Quality

General Notices

• Notice of Webinar for RFA-DA-20-025, "Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research (U18-Clinical Trials Not Allowed)
  National Institute on Drug Abuse

• Notice of Intent to Publish a Funding Opportunity Announcement for Drug Development Tools Research Grants
  Food and Drug Administration

• FDA Requires Mandatory Use of the Prior Approval Module in eRA Commons beginning January 1, 2020
  Food and Drug Administration

• NHLBI Announces Plan to Fund a Framingham Heart Study Exam for the Generation 3 and Omni 2 Cohorts
  National Heart, Lung, and Blood Institute

• Findings of Research Misconduct
  National Institutes of Health

• Reminder of application instructions and policies impacting SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance PAR-19-333, PAR-19-334, and PAR-19-335
  National Institutes of Health

• Notice for the All of Us Participant Technology Systems Center (OT2) Funding Opportunity and Informational Webinar
  National Institutes of Health

• Request for Information: Input to the National Eye Institute Strategic Plan: 2020 Vision for the Future
  National Eye Institute

• Request for Information (RFI) on the 2020 National Institute of Mental Health (NIMH) Strategic Plan for Research
  National Institute of Mental Health

• Request for Information (RFI): Increasing the diversity of applications to the NIH Common Fund High-Risk, High-Reward Research Program
  Office of Strategic Coordination (Common Fund)

Notice of Changes to Funding Opportunities

• Notice of Early Expiration of PAS-19-097 "Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)"
  National Institute of Allergy and Infectious Diseases

• Notice of NIDA Participation in PAR-20-036 "Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)"
  National Institute on Drug Abuse

• Notice of Corrected Application Forms for RFA-DE-20-005 National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional)
  National Institute of Dental and Craniofacial Research

• Notice of Extension of the Response Date for NOT-NS-19-080 "Solicitation of Nominations for the 2020 National Institute of Neurological Disorders and Stroke (NINDS) Landis Award for Outstanding Mentorship"
  National Institute of Neurological Disorders and Stroke

• Notice of Additional Receipt Dates for PAR-18-848 Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional)
  Office of Disease Prevention
  National Institute on Drug Abuse

• Notice of Additional Receipt Dates for PAR-18-847 Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional)
  Office of Disease Prevention
  National Institute on Drug Abuse

• Notice of Additional Receipt Dates for PAR-18-846 Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)
  Office of Disease Prevention
  National Institute on Drug Abuse

• Notice of Additional Receipt Dates for PAR-18-845 Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)
  Office of Disease Prevention
  National Institute on Drug Abuse

• Notice to Withdraw the Centers for Disease Control and Prevention (CDC) as a Participating Organization from PAR-19-334 entitled "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed"
  National Institutes of Health

• Notice of Change to Eligibility Information and Application Instructions in RFA-RM-20-003 Real Time Chromatin Dynamics and Function (U01 Clinical Trial Not Allowed)
  Office of Strategic Coordination (Common Fund)

• Notice of Change to Eligibility Information and Application Instructions in RFA-RM-20-004 4DN Centers for Data Integration, Modeling and Visualization (UM1 Clinical Trial Not Allowed)
  Office of Strategic Coordination (Common Fund)

• Notice of Change to Eligibility Information and Application Instructions in RFA-RM-20-005 4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed)
  Office of Strategic Coordination (Common Fund)

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Sickle Pan-African Research Consortium (SPARCO) collaborative sites (U01 Clinical Trial Not Allowed)
  National Heart, Lung, and Blood Institute

Notices of Special Interest

• Notice of Special Interest: Alzheimers-focused administrative supplements for NIH grants that are not focused on Alzheimers disease
  National Institute on Aging
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities 
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

• Notice of Special Interest (NOSI): Small Business Research in Biomedical Imaging and Bioengineering
  National Institute of Biomedical Imaging and Bioengineering

• Notice of Special Interest: Understanding the Biology of Iodine Nutrition, Assessment, and Outcomes (R01, R21, R03, R43/R44, R41/R42)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  Office of Dietary Supplements

• Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
  National Institutes of Health
  National Cancer Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research

• Notice of Special Interest (NOSI): Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE Project
  National Institutes of Health
  National Cancer Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research

• Notice of Special Interest: Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional)
  Office of the Director, NIH
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities 
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health

Funding Opportunities

• AHRQ Mentored Research Scientist Career Development Award (K01)
  Agency for Healthcare Research and Quality
  
   
• Improving Quality of Care and Patient Outcomes During Care Transitions (R01)
  Agency for Healthcare Research and Quality
  
   
• NIA Research Centers Collaborative Network (RCCN) (U24 Clinical Trial Optional)
  (RFA-AG-21-001)
  National Institute on Aging
  Application Receipt Date(s): May 15, 2020 
  
   
• Emotional Well-Being: High-Priority Research Networks (U24, Clinical Trial Optional)
  National Center for Complementary and Integrative Health
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  
   
• Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
  National Cancer Institute
  
   
• Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
  National Cancer Institute
  
   
• Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
  National Cancer Institute
  
   
• Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
  National Cancer Institute
  
   
• Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)
  National Institute of Diabetes and Digestive and Kidney Diseases
  
   
• Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required)
  National Institute of Diabetes and Digestive and Kidney Diseases
  
   
• National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  
   
• Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trial Not Allowed)
  Office of Strategic Coordination (Common Fund)
  
   
• Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trial Not Allowed)
  Office of Strategic Coordination (Common Fund)

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu